CLINICAL SUPPLY MANUFACTURING VIDEOS

Early planning mitigates risk by avoiding stock outs and study delays, minimizing waste with optimized inventory, and forecasting demand to facilitate robust supply planning.

This session presents a risk-based framework for high-potency micronisation, illustrated through a practical case study that spans development to commercial scale.

Expert speakers discuss current operational obstacles and explore strategic solutions to optimize a supply chain strategy in the years ahead.

Susan Dexter, Chief Technical Officer, Sonnet BioTherapeutics, describes the good choices she made, and one not-so-good choice, in trying to untie a knotted supply chain.

CLINICAL SUPPLY MANUFACTURING RESOURCES